Cassava Sciences (MEX:SAVA) Total Assets : MXN4,462.19 Mil (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Cassava Sciences Total Assets?

Cassava Sciences's Total Assets for the quarter that ended in Jun. 2024 was MXN4,462.19 Mil.

During the past 12 months, Cassava Sciences's average Total Assets Growth Rate was 25.90% per year. During the past 3 years, the average Total Assets Growth Rate was 237.50% per year. During the past 5 years, the average Total Assets Growth Rate was 210.20% per year. During the past 10 years, the average Total Assets Growth Rate was 65.10% per year.

During the past 13 years, Cassava Sciences's highest 3-Year average Total Assets Growth Rate was 364.80%. The lowest was -67.80%. And the median was 2.90%.

Total Assets is connected with ROA %. Cassava Sciences's annualized ROA % for the quarter that ended in Jun. 2024 was 12.80%. Total Assets is also linked to Revenue through Asset Turnover. Cassava Sciences's Asset Turnover for the quarter that ended in Jun. 2024 was 0.00.

Cassava Sciences Total Assets Historical Data

The historical data trend for Cassava Sciences's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cassava Sciences Total Assets Chart

Cassava Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

442.95

1,875.82

5,472.77

4,578.32

2,574.37

Cassava Sciences Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Total Assets	Get a 7-Day Free Trial															3,381.60	3,005.27	2,574.37	2,584.34	4,462.19

Cassava Sciences Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Cassava Sciences's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	2333.416	+	240.949
	=	2,574.37

Cassava Sciences's Total Assets for the quarter that ended in Jun. 2024 is calculated as

Total Assets	=	Total Equity (Q: Jun. 2024 )	+	Total Liabilities (Q: Jun. 2024 )
	=	3462.023	+	1000.168
	=	4,462.19

Cassava Sciences (MEX:SAVA) Total Assets Explanation

Total Assets is connected with ROA %.

Cassava Sciences's annualized ROA % for the quarter that ended in Jun. 2024 is

ROA %	=	Net Income (Q: Jun. 2024 )	/	( (Total Assets (Q: Mar. 2024 )	+	Total Assets (Q: Jun. 2024 ))	/ count )
	=	451.04	/	( (2584.336	+	4462.191)	/ 2 )
	=	451.04	/	3523.2635
	=	12.80 %

Note: The Net Income data used here is four times the quarterly (Jun. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Cassava Sciences's Asset Turnover for the quarter that ended in Jun. 2024 is

	Asset Turnover
=	Revenue (Q: Jun. 2024 )	/	( (Total Assets (Q: Mar. 2024 )	+	Total Assets (Q: Jun. 2024 ))	/ count )
=	0	/	( (2584.336	+	4462.191)	/ 2 )
=	0	/	3523.2635
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Cassava Sciences Total Assets Related Terms

Thank you for viewing the detailed overview of Cassava Sciences's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Cassava Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cassava Sciences Inc (MEX:SAVA) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

SAVA:USA PX91:Germany PX91:Germany

Address

6801 N. Capital of Texas Highway, Suite 300, Building 1, Austin, TX, USA, 78731

Website

https://www.cassavasciences.com

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia.